Skip to content

Author

Runming Zhong

We have 1 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

iRGD-targeted nanoliposomes for hypoxia-relieved sonodynamic and ferroptosis-enhanced chemodynamic combination cancer therapy.

The as-prepared iRGD-targeted nanoliposomes exhibit remarkable synergistic antitumor efficacy, inducing extensive tumor necrosis, apoptosis, and ferroptosis while causing minimal systemic side effects, demonstrating great application potential for future breast cancer therapy.

Runming Zhong, Yingzhe Wu, Yanzhen Lou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.